Keqin Hua
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 62
- Uterine Myomas and Treatments 39
- Gynecological conditions and treatments 35
- Reproductive Medicine top 0.5%
- Endometriosis Research and Treatment 44
- Ovarian cancer diagnosis and treatment 32
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 33
- Immunology top 5%
- Molecular Biology top 5%
-
- Pelvic floor disorders treatments 35
-
- Cervical Cancer and HPV Research 26
- Journals
- SHILAP Revista de lepidopterología (3 papers)ACS Nano (1 paper)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Keqin Hua
248 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 131
- Obstetrics and Gynecology 1.1k
- Reproductive Medicine 838
- Cancer Research 1.3k
- Immunology 589
- Molecular Biology 1.8k
Countries citing papers authored by Keqin Hua
This map shows the geographic impact of Keqin Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keqin Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keqin Hua more than expected).
Fields of papers citing papers by Keqin Hua
This network shows the impact of papers produced by Keqin Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keqin Hua. The network helps show where Keqin Hua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keqin Hua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 52 | |
| 8 | 2023 | 32 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 62 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 2 | |
| 16 | 2021 | 69 | |
| 17 | 2020 | 13 | |
| 18 | 2015 | 1 | |
| 19 | Relationship of advanced glycation end products and their receptor to pelvic organ prolapse. | 2015 | 18 |
| 20 | 2012 | 15 |
About Keqin Hua
Keqin Hua is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 269 papers that have together received 4.4k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (62 papers), Endometriosis Research and Treatment (44 papers), Uterine Myomas and Treatments (39 papers), Pelvic floor disorders treatments (35 papers), Gynecological conditions and treatments (35 papers), Cancer-related molecular mechanisms research (33 papers), Ovarian cancer diagnosis and treatment (32 papers) and Cervical Cancer and HPV Research (26 papers). The work is most often cited by research in Obstetrics and Gynecology (1.1k citations), Reproductive Medicine (838 citations) and Cancer Research (1.3k citations). Keqin Hua has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Junjun Qiu, Jingxin Ding, Chunbo Li, Jingxin Ding, Xuyin Zhang, Yingying Lin, Yisong Chen, Hongyan Jin, Weiwei Feng and Xiaoyan Tang. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.